Systemic infections can decrease the threshold of statin-induced muscle injury.
Mahboobi
Sohail K
SK
Shohat
Ephron Z
EZ
Jellinek
Samantha P
SP
Rose
Malcolm
M
D058186:Acute Kidney Injury / Q000209:etiology*; D000369:Aged, 80 and over; D000069059:Atorvastatin; D016470:Bacteremia / Q000382:microbiology*; D013293:Enterococcus faecalis / Q000302:isolation & purification; D004926:Escherichia coli / Q000302:isolation & purification; D006350:Heart Valve Prosthesis; D006538:Heptanoic Acids / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000008:administration & dosage / Q000009:adverse effects*; D008297:Male; D009135:Muscular Diseases / Q000139:chemically induced* / Q000150:complications; D011758:Pyrroles / Q000008:administration & dosage / Q000009:adverse effects*
D006538:Heptanoic Acids; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D011758:Pyrroles; D000069059:Atorvastatin